首页 | 本学科首页   官方微博 | 高级检索  
检索        

拉米夫定治疗102例慢性重度乙型肝炎近期疗效观察
引用本文:胡章勇,杨军,黄赛,夏绍碧,刘福元.拉米夫定治疗102例慢性重度乙型肝炎近期疗效观察[J].四川医学,2011,32(5):661-662.
作者姓名:胡章勇  杨军  黄赛  夏绍碧  刘福元
作者单位:成都医学院第一附属医院感染科,四川,成都,610500
摘    要:目的探讨拉米夫定抗病毒治疗对慢性重度乙型肝炎预后的影响。方法将197例慢性重度乙肝患者随机分为治疗组和对照组,对照组接受综合护肝治疗措施,治疗组在此基础上,服用拉米夫定100mg/d,治疗8周。结果在治疗第8周,治疗组谷丙转氨酶、总胆红素及血清HBV DNA的下降水平明显优于对照组(P〈0.01);凝血酶原活动度较治疗前显著升高,但以治疗组更为明显;在治疗组中,重型肝炎的发生率、病死率和并发症的发生率均显著低于对照组。结论拉米夫定能在短期内阻断部分慢性重度乙型肝炎进展,提高存活率,减少并发症发生率。

关 键 词:慢性重度乙型肝炎  DNA病毒  治疗  拉米夫定

Short-term efficacy of lamivudine for 102 patients with chronic severe-degree hepatitis B
HU Zhang-yong,YANG Jun,HUANG Sai,et al..Short-term efficacy of lamivudine for 102 patients with chronic severe-degree hepatitis B[J].Sichuan Medical Journal,2011,32(5):661-662.
Authors:HU Zhang-yong  YANG Jun  HUANG Sai  
Institution:HU Zhang-yong,YANG Jun,HUANG Sai,et al.The First Affiliated Hospital of Chengdu Medical College,Chengdu,Sichuan 610500,China
Abstract:Objective To evaluate the effect of lamivudine for patients with chronic severe-degree hepatitis B.Methods 197 patients with chronic severe-degree hepatitis B were randomly divided into a conventional supporting treatment control group and a lamivudine treatment group.In the latter,102 patients were given lamivudine orally at a dose of 100mg every day besides the support care which was also given to the control group.Results After therapy for 8 weeks,total bilirubin and alanine aminotransferase levels of la...
Keywords:chronic hepatitis B  DNA virus  treatment  lamivudine  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号